4상상태 미확인

Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity

연구 개요

Study Design: Randomized Single Blind Study Objective: To determine the dose relationship of DWP 450 for finger flexor spasticity Subjects: 78 patients with upper extremity spasticity after CVA Inclusion criteria: Patient who have spasticity (MAS greater than 2 in finger flexors) Methods: Patients will be randomly assigned to one of 5 groups. Gp 1: placebo, Gp 2: 15U, Gp 3: 30 U, Gp 4: 50 U, Gp 5: 75 U

스폰서: 협력: 대웅제약
적응증: Spasticity as Sequela of Stroke
중재: Normal Saline 0.9% 1.2 ml, Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 15 U, Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 30 U, Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U, Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 70 U
목표 등록: 78명
시작일: 2016-09-01
완료(예정): 2018-06-01
등록번호: NCT03517319 · ClinicalTrials.gov ↗

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.